Beta-Glucan for Cholesterol

Verdict: Cereal beta-glucan modestly lowers cholesterol

Soluble beta-glucan from oats and barley reliably lowers LDL and total cholesterol by a modest amount (roughly 5-10%), making it a useful dietary adjunct rather than a replacement for statins. The evidence is consistent and regulator-backed, but it rests on cholesterol blood markers rather than proven reductions in heart attacks or strokes, which keeps this a preliminary (B) verdict.

B 🟡 B Preliminary Evidence Published

🔬Why this grade7-layer evidence engine

Four high-quality meta-analyses converge on a real but small effect. Pooled oat-beta-glucan trials lowered LDL-C by 0.19-0.27 mmol/L and total cholesterol by 0.24-0.30 mmol/L (PMID 27724985 across 58 RCTs, n=3,974; PMID 25411276 across 28 RCTs; PMID 35631184 across 13 RCTs in hypercholesterolemic adults), and barley beta-glucan showed a near-identical LDL drop of 0.25 mmol/L (PMID 27273067, 14 RCTs). The effect appears around 3 g/day and is larger in people with higher baseline LDL or diabetes; HDL and triglycerides were unchanged.

Regulators and major clinics agree. The US FDA grants an authorized health claim that soluble fiber from oats and barley, within a low-saturated-fat diet, may reduce heart-disease risk (21 CFR 101.81), and the Mayo Clinic states the beta-glucan in oats lowers cholesterol. This unusually strong institutional backing is why the result is published with reasonable confidence.

Why a B and not an A: every graded outcome is a surrogate lipid marker, not a hard cardiovascular endpoint, and the absolute effect is adjunct-sized rather than therapeutic. The evidence applies only to cereal (oat/barley) beta-glucan, not the yeast or mushroom form sold for immunity, and processing that degrades high-molecular-weight beta-glucan can blunt the benefit, so commercial products may underperform trial conditions.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable

Raw score 0.70

← counter-evidence / ineffectiveeffective / strong evidence →

Final grade

B · Published

Confidence

80%

Highly consistent evidence

Evidence level

Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive

L1 ExamineGlobal benchmark

0.50

L3 MechanismPlausibility

0.65

L11 AI re-checkIndependent read

0.65

L2 PubMedPrimary literature

0.70

L5 Clinical bodiesAuthoritative stance

0.85

Against Mixed Supports

▸View the full decision path (audit trail)

compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.7
tier_from_score — 依分數區間映射至 tier letter
apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
tier_strict_requirement_check — | A→B 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials

PMID: 27724985 2016 統合分析 n = 3,974

Finding: Across 58 RCTs, oat beta-glucan significantly reduced LDL-C (-0.19 mmol/L, 95% CI -0.23 to -0.14, p<0.00001), non-HDL-C (-0.20 mmol/L, 95% CI -0.26 to -0.15) and apoB (-0.03 g/L, 95% CI -0.05 to -0.02).

🟢 High quality Effect size: LDL-C -0.19 mmol/L; non-HDL-C -0.20 mmol/L; apoB -0.03 g/L

View on PubMed

Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials

PMID: 25411276 2014 統合分析

Finding: Across 28 RCTs, oat beta-glucan ≥3 g/day reduced LDL-C by 0.25 mmol/L (95% CI 0.20-0.30) and total cholesterol by 0.30 mmol/L (95% CI 0.24-0.35) vs control; no effect on HDL-C or triglycerides. Effect was greater with higher baseline LDL-C and in subjects with diabetes.

🟢 High quality Effect size: LDL-C -0.25 mmol/L; total cholesterol -0.30 mmol/L

View on PubMed

A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction

PMID: 27273067 2016 統合分析 n = 615

Finding: Across 14 RCTs, barley beta-glucan significantly reduced LDL-C by 0.25 mmol/L (95% CI -0.30 to -0.20) and non-HDL-C by 0.31 mmol/L (95% CI -0.39 to -0.23); apoB showed no significant change.

🟢 High quality Effect size: LDL-C -0.25 mmol/L; non-HDL-C -0.31 mmol/L; apoB NS

View on PubMed

Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PMID: 35631184 2022 統合分析 n = 927

Finding: Across 13 RCTs in hypercholesterolemic adults, oat beta-glucan significantly reduced total cholesterol (WMD -0.24 mmol/L, 95% CI -0.28 to -0.20) and LDL-C (WMD -0.27 mmol/L, 95% CI -0.35 to -0.20); no significant change in triglycerides or HDL-C.

Government Effect size: Total cholesterol -0.24 mmol/L; LDL-C -0.27 mmol/L

View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA

Supportive

Soluble fiber from foods such as [name of soluble fiber source and, if desired, name of food product], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food product] supplies __ grams of the [necessary daily dietary intake for the benefit] soluble fiber from [name of soluble fiber source] necessary per day to have this effect. source↗

L4b EU EFSA

Neutral

L4c UK NHS

Neutral

L4d TW TFDA / 衛福部

Neutral

桂格即沖即食大燕麥片獲得「不易形成體脂肪」與「調節血脂」兩項健康食品認證；桂格原片原味大燕麥片獲得「調節血脂」功效之健康食品認證。 source↗

L5a NIH Office of Dietary Supplements

Cautious

L5b Mayo Clinic

Supportive

Oats contain a type of soluble fiber called beta-glucan, which lowers blood glucose and cholesterol levels and reduces the risk of heart disease and diabetes. source↗

L5c Cleveland Clinic

Supportive

L5d Harvard Health

Supportive

L5e Specialty Society (condition-mapped)

Supportive

✓PMID 100% verifiedevery citation checked via NCBI Entrez

🔬4 PubMed studiesindependently re-checked by multiple sub-agents

engine_version: v1.0 claim_id: CLM-COND-cholesterol-INT-beta-glucan-001 繁體中文版 →